Senior insider sale
CSBO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$799.2K
29.18K shares
What this filing means
DANDEKAR ATUL plans to sell 29.18K shares of MAZE THERAPEUTICS, INC. valued at approximately $799.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0002050167-26-000024
Officer· CSBO
Since Feb 2026
29.18K
Shares to sell
$799.2K
Approx. market value
6.68K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
9/1/2026
6.68KTotal acquired6.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Restricted Stock Unit Vesting Compensation | 6.68K | — |
| Total | 6.68K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.50K
Market value
$206.8K
8/28/2026
—Completed
Units to sell
7.50K
Market value
$205.0K
7/29/2026
—Completed
Units to sell
7.50K
Market value
$210.2K
6/29/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.68K
Market value
$177.2K
9/2/2026
Total
Units
29.18K
Value
$799.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/28/2026 | 7.50K | $206.8K | — | Completed |
7/29/2026 | 7.50K | $205.0K | — | Completed |
6/29/2026 | 7.50K | $210.2K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 6.68K | $177.2K | NASDAQ | Planned |
| Total | 29.18K | $799.2K | ||